Newsletter | August 7, 2026

08.07.26 -- Inside ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive T-Cell Malignancies

SPONSOR

11th CAR TCR Summit

Join the 11th CAR TCR Summit, the leading forum dedicated to advancing next generation cell therapies. Bringing together industry leaders, biopharma innovators, and clinical experts, this meeting explores manufacturing, clinical development, solid tumor strategies, and emerging approaches shaping the future of CAR T and TCR therapies.

FOCUS ON CLINICAL TRIALS

ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive Malignancies

ImvivaBio CMO Jan Davidson-Moncada, MD, Ph.D., discusses the company's Phase 1b/2 study for aggressive T-cell malignancies, explaining their unmet need, the rationale for an allogeneic approach, and how they plan to address immune rejection.

The Role Of Oncology Biomarkers In Personalizing Hematology Treatment Plans

Oncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.

Accelerating Rare Disease Access Through Global Alignment

Rare disease innovation is accelerating, but fragmented regulations, inconsistent data standards, and limited natural history data can slow progress. Global alignment is key to faster patient access.

Unifying Research - Patient Negative One And Christine Von Raesfeld

Clinical research innovation and patient advocacy meet in a conversation about AI, ethics, autonomy, and trust, highlighting how bold ideas and lived experience help shape a more responsible future.

Barcode-Driven Verification: Enhancing Compliance

Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.

CLINICAL TRIALS SOLUTIONS

Reviewing Protocols Across Therapeutic Areas - BRANY

Home Trial Support That Maintains Patient Safety - MRN - Medical Research Network

FOCUS ON SUPPLY CHAIN

Best Practices For Managing The Logistics And Distribution Of CGTs

Site infrastructure, formulary timelines, and storage capabilities create barriers between approval and patient access. Planning for these operational realities separates successful launches from stalled ones.

Resolving Common Single-Use Concerns

Demand for single-use production tools, components, expertise, and capabilities continues to grow as innovative cell therapies evolve. However, concerns and misconceptions abound regarding single-use solutions.

SUPPLY CHAIN SOLUTIONS

Ultra-Low Temperature Storage Freezer | RoSS.ULTF - Single Use Support

Connect With Cell & Gene: